7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 
      
                                 
      cash flows from operating activities:
                                 
      net income
    18,435,000 17,832,000 8,539,000 -8,888,000 -12,693,000 -3,908,000 -17,704,000 25,237,000 -13,855,000 14,972,000 -12,270,000 4,461,000 224,093,000 -19,981,000 -25,210,000 -36,333,000 -30,544,000 -41,563,000 -49,484,000 -53,657,000 -43,836,000 -37,469,000 -26,419,000 -31,797,000 -27,058,000 -37,191,000 -65,821,000 -42,580,000 -24,406,000 
      adjustments to reconcile net income to net cash from operating activities
                                 
      depreciation and amortization expense
    384,000 358,000 345,000 400,000 399,000 430,000 466,000 540,000 603,000 602,000 596,000 602,000 493,000 651,000 656,000 668,000 658,000 717,000 312,000           
      share-based compensation expense
    10,144,000 8,876,000 7,748,000 8,298,000 7,826,000 7,363,000 7,206,000 7,773,000 6,788,000 6,473,000 6,115,000 6,372,000 6,041,000 6,676,000 6,031,000 6,131,000 6,199,000 5,717,000 7,126,000 6,257,000 5,558,000 4,851,000 4,209,000 4,965,000 3,758,000 3,464,000 2,893,000 2,582,000 1,502,000 
      non-cash lease expense
    944,000 924,000 835,000 767,000 754,000 836,000 779,000 737,000 707,000 769,000 841,000 788,000 772,000 746,000 735,000 736,000 702,000 600,000 593,000 639,000 158,000 303,000 300,000       
      net amortization of premiums and accretion of discounts on short-term investments
    603,000                             
      net gain on disposal of property and equipment
    -43,000                             
      deferred income taxes
    4,227,000 2,644,000 2,993,000 -3,163,000 -3,639,000 10,569,000 4,365,000 -25,709,000 10,288,000 -19,444,000 1,077,000 348,000       10,000 40,000 -51,000 5,410,000 -1,038,000 255,000 -2,021,000 -1,150,000 -240,000 -43,000  
      changes in operating assets and liabilities:
                                 
      prepaid expenses and other current assets
    2,030,000 -6,868,000 -5,327,000 13,799,000 -6,992,000 -13,267,000 3,750,000 8,845,000 -13,987,000 709,000 -2,634,000 4,868,000 -1,305,000 -3,489,000 -3,932,000               
      accounts receivable
    -19,832,000 8,155,000 1,659,000 -16,836,000 -4,437,000 -4,456,000 5,271,000 -18,225,000 21,609,000 -17,226,000 5,236,000 -1,501,000 -3,351,000 21,632,000 -25,455,000 -686,000 -673,000             
      inventory
    6,785,000 -26,112,000 4,295,000 2,316,000 6,178,000 -7,580,000 3,844,000 -5,539,000 -1,625,000 -533,000 -1,826,000 -6,978,000 5,295,000 -6,693,000 -9,548,000 1,931,000 775,000             
      other long-term assets
    -143,000 -70,000 2,045,000 -2,524,000 -10,000 -3,839,000 -3,362,000 1,406,000 -90,000 3,268,000 -265,000 1,000 163,000 2,755,000 -2,225,000 -780,000 -48,000 -231,000           
      accounts payable
    -2,728,000 6,930,000 62,000 -6,284,000 911,000 1,729,000 -2,662,000 7,234,000 364,000 -743,000 -6,508,000 6,430,000 -1,053,000 -861,000 1,515,000 250,000 -2,538,000 3,582,000 72,000 -3,265,000 1,524,000 -2,031,000 -1,197,000 -201,000 -2,841,000 1,680,000 -3,343,000 5,842,000  
      accrued expenses, accrued collaboration expenses and other current liabilities
    8,368,000 13,098,000 -3,596,000 10,993,000 10,796,000                         
      operating lease liabilities
    -760,000 -925,000 -852,000 -788,000 -877,000 -1,032,000 -1,287,000 -706,000 -741,000 -826,000 -988,000 -790,000 -781,000 -793,000 -643,000 -853,000 -837,000 -442,000 -421,000 -594,000 -272,000 -420,000 -413,000 -348,000 -314,000 -309,000 -293,000   
      deferred revenue
       20,000,000 -1,000 -155,000 -294,000 -2,175,000 -2,244,000 -1,978,000 6,658,000 -14,290,000 14,290,000 12,000,000               
      other long-term liabilities
    5,263,000 4,126,000 3,313,000 -139,000 36,000 35,000 33,000 -87,000 30,000 31,000 45,000 19,000 1,560,000 -11,000 1,000 -615,000 -257,000 333,000 4,000 -152,000 623,000 -48,000 55,000 -617,000 434,000 509,000   
      net cash from operating activities
    33,677,000 28,090,000 22,324,000 18,770,000 -2,236,000 5,168,000 3,987,000 4,325,000 16,986,000 -3,743,000 -4,267,000   -7,824,000 -36,846,000 -18,884,000 -28,509,000 -38,783,000 -40,122,000 -41,191,000 -34,321,000 -29,224,000 -31,796,000 -24,170,000 -29,267,000 -41,676,000 -63,256,000 -27,638,000  
      capex
    -722,000 139,000 -65,000 -193,000 23,000 76,000 18,000 -56,000 -16,000 -34,000 -24,000   -251,000 -51,000 -59,000 -54,000 -55,000 -5,000 -223,000 -1,996,000 -440,000 794,000 -1,561,000 -4,016,000  
      free cash flows
    32,955,000 28,229,000 22,259,000 18,577,000 -2,213,000 5,244,000 4,005,000 4,269,000 16,970,000 -3,777,000 -4,291,000   -7,824,000 -36,846,000 -19,135,000 -28,560,000 -38,842,000 -40,176,000 -41,246,000 -34,326,000 -29,224,000 -32,019,000 -26,166,000 -29,707,000 -40,882,000 -64,817,000 -31,654,000  
      cash flows from investing activities:
                                 
      proceeds from sale of property and equipment
             10,000 -10,000                 
      purchases of property and equipment
    -671,000 -165,000 -99,000 -193,000 -84,000 -56,000 -16,000 -34,000 -24,000 32,000 -22,000   -251,000 -51,000 -59,000 -54,000 -55,000 -5,000 -223,000 -1,996,000 -440,000 794,000 -1,561,000 -4,016,000  
      purchases of short-term investments
    -146,160,000 -34,323,000 -95,470,000 -21,994,000 -54,481,000 -89,263,000 -36,276,000 -60,817,000 -53,088,000 -38,132,000 -52,896,000 -62,802,000 -17,328,000 -25,511,000 -30,223,000 -59,790,000 -23,098,000 -74,362,000 -86,052,000 -210,205,000 -107,767,000 -26,187,000 -82,638,000 -132,647,000 -91,681,000 -181,807,000 -109,424,000  
      proceeds from the maturities of short-term investments
    84,076,000 30,605,000 44,028,000 87,480,000 48,133,000 42,441,000 61,884,000 45,979,000 40,827,000 73,700,000 15,000,000 20,100,000 36,400,000 63,800,000 7,500,000 10,000,000 47,900,000 109,150,000 139,250,000 154,750,000 60,550,000 76,550,000 115,200,000 86,550,000 148,300,000 132,250,000 174,090,000 143,100,000  
      net cash from investing activities
    -62,755,000 -3,883,000 -51,541,000 65,293,000 -6,348,000 -46,797,000 25,524,000 -14,894,000   -37,920,000 -42,660,000 19,040,000 38,265,000 -22,723,000 -50,041,000 47,849,000 85,993,000 44,834,000 68,643,000 -149,660,000 -31,217,000 88,790,000 1,916,000 15,213,000 41,363,000 -9,278,000 29,660,000  
      cash flows from financing activities:
                                 
      proceeds from issuance of class a ordinary shares under incentive award plans and employee share purchase plan
    16,252,000 12,745,000 3,180,000 2,720,000 9,401,000                         
      payments in connection with ordinary shares tendered for employee tax obligations
    -4,353,000 -2,047,000 -412,000                           
      net cash from financing activities
    11,899,000 10,698,000 2,768,000 2,142,000 6,689,000 -178,000 3,613,000 695,000 552,000 158,000 90,000 1,190,000 361,000 542,000 423,000 1,212,000 2,680,000 887,000 1,106,000 712,000 146,399,000 77,561,000 2,414,000 373,000 53,000 494,000 83,187,000 291,000 -762,000 
      net decrease in cash and cash equivalents
        -1,895,000    5,261,000 31,949,000 -42,097,000                   
      cash and cash equivalents at beginning of period
    183,581,000 107,954,000  122,715,000                   
      cash and cash equivalents at end of period
    -17,179,000 34,905,000 157,132,000 86,205,000 -1,895,000 -41,807,000 141,078,000  5,261,000 31,949,000 80,618,000                   
      ​
                                 
      supplemental information:
                                 
      cash paid for income taxes
    1,000 3,008,000 1,262,000 -769,000   -1,312,000 201,000 3,520,000 3,196,000 6,081,000 1,315,000   420,000 5,000   200,000   -3,000 700,000   38,000 197,000 
      supplemental disclosure of non-cash investing and financing activities:
                                 
      change in right-of-use asset as a result of new, modified, and terminated leases
    713,000 775,000 912,000 48,000 70,000 291,000 1,172,000 184,000                     
      additions to property and equipment included in accounts payable and accrued expenses and other liabilities
    -51,000 304,000 34,000  23,000 76,000 102,000                       
      net increase in cash and cash equivalents
     34,905,000 -26,449,000    33,124,000                       
      amortization of premiums and accretion of discounts on short-term investments
      255,000  -487,000 -188,000 297,000  1,441,000 -1,152,000 -1,061,000  -119,000 76,000 164,000  14,000 193,000 410,000           
      net income on disposal of property and equipment
      10,000                           
      adjustments to reconcile net income to net cash from operating activities:
                                 
      amortization (accretion) of discounts on short-term investments
                                 
      gain on disposal of property and equipment
                               
      loss on disposal of property and equipment
         4,000 175,000 10,000 -11,000           -2,000    
      contract asset
           7,656,000                   
      payments in connection with ordinary stock tendered for employee tax obligations
       -578,000 -2,712,000                         
      additions to property and equipment included in accrued expenses and other liabilities
                                 
      accrued expenses and other current liabilities
          3,285,000 5,286,000 7,608,000 14,693,000 -10,647,000 -3,791,000 1,971,000 -5,974,000 4,085,000               
      proceeds from issuance of class a common shares under incentive award plans and employee share purchase plan
          3,994,000 957,000 1,657,000 577,000 510,000 1,290,000 569,000 566,000 992,000 1,212,000 2,680,000             
      payments in connection with common stock tendered for employee tax obligations
          -381,000 -262,000 -1,105,000 -419,000 -420,000 -100,000 -208,000 -24,000 -569,000               
      intangible assets acquired
                                 
      net increase in cash, cash equivalents and restricted cash
               -53,046,000 81,454,000 30,983,000 -59,146,000 -67,713,000 22,020,000 48,097,000 5,818,000 28,164,000 -37,582,000 17,120,000 59,408,000       
      cash, cash equivalents and restricted cash at beginning of period
               122,470,000 114,248,000 47,138,000       
      cash, cash equivalents and restricted cash at end of period
               -53,046,000 81,454,000 30,983,000 63,324,000 -67,713,000 22,020,000 48,097,000 120,066,000 28,164,000 -37,582,000 17,120,000 106,546,000       
      net cash provided (used) in investing activities
                                 
      right-of-use asset obtained in exchange for operating lease obligation
              684,000    157,000              
      proceeds from issuance of class a common shares from follow-on offerings, net of underwriting discounts and commissions, inclusive of the over-allotment option exercise
                                
      proceeds from issuance of class a1 common shares from private placements, net of placement agent fees
                                
      payments of offering costs
                       -160,000 -407,000   -18,000 -100,000   
      net cash provided (used) in operating activities
                                 
      intangible asset acquired
                    -20,000,000           
      class a common shares issued as consideration for primatope, including milestone payments
                                 
      accrued milestones
                           -150,000 150,000 -13,000,000 -2,000,000   
      property and equipment included in accrued expenses and accounts payable
                           -149,000 118,000 216,000 37,000 234,000  
      prepaid expenses and other assets
                    1,230,000 -604,000 408,000  -1,925,000 -3,245,000 -598,000     -764,000  
      accrued expenses and other liabilities
                    -2,458,000 1,674,000 1,079,000  3,177,000 2,915,000 -7,061,000 1,953,000 -35,000 3,096,000 -376,000   
      proceeds from issuance of class a common shares from follow-on offering, net of underwriting discounts and commissions, inclusive of the over-allotment option exercise
                                 
      proceeds from issuance of class a1 common shares from private placement, net of placement fees
                                 
      deferred offering costs included in accrued expenses and accounts payable
                        -181,000      19,000 393,000 -845,000 
      proceeds from issuance of class a common shares under incentive award plans
                      1,106,000           
      depreciation expense
                       567,000 649,000 595,000 594,000 566,000 523,000 508,000 471,000 254,000 12,000 
      other
                                 
      prepaid expenses and other short-term assets
                                 
      accrued expenses and other short-term liabilities
                                 
      proceeds from issuance of series c convertible preferred shares, net of issuance costs
                               
      proceeds from issuance of class a common shares upon completion of initial public offering, net of underwriting discounts and commissions, inclusive of the over-allotment option exercise
                                 
      class a common shares issued or to be issued as consideration for primatope, including milestone payments
                               
      accretion of discounts on short-term investments
                        74,000 -85,000 -228,000 -457,000 -989,000 -1,209,000 -846,000 -753,000  
      proceeds from exercise of options and employee share purchase plan
                        331,000 2,936,000 2,414,000 373,000 53,000 512,000 181,000   
      proceeds from issuance of class a1 common shares from private placement, net of placement agent fees
                                 
      proceeds from issuance of class a common shares from follow-on offering, net of underwriting commissions and discounts, inclusive of the over-allotment option exercise
                           48,595,000   
      proceeds from issuance of class a1 common shares from private placement, net of underwriting commissions and discounts
                           34,511,000   
      proceeds from issuance of class a common shares upon completion of initial public offering, net of underwriting commissions and discounts, inclusive of the over-allotment option exercise
                                 
      net increase in cash and cash equivalents and restricted cash
                           -21,881,000 -14,001,000 181,000 10,653,000 2,313,000 -216,118,000 
      cash, cash equivalents, and restricted cash at beginning of period
                                 
      cash, cash equivalents, and restricted cash at end of period
                                 
      non-cash rent expense
                               -23,000 50,000 
      prepaid expenses, right-of-use assets and other assets
                            -463,000 201,000 -1,210,000   
      cash and cash equivalents and restricted cash at beginning of period
                            72,186,000 
      cash and cash equivalents and restricted cash at end of period
                            -14,001,000 181,000 82,839,000 2,313,000 -216,118,000 
      class a common shares issued or to be issued as consideration for primatope
                              7,000,000   
      proceeds from issuance of series b convertible preferred shares, net of issuance costs
                                 
      accrued expenses
                                833,000 
      proceeds from issuance of class a common shares upon completion of initial public offering, net of underwriting commissions and discounts
                                
      payments of deferred offering costs
                                 
      proceeds from exercise of options
                                59,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.